VARANA Trademark

Trademark Overview

On Thursday, August 2, 2001, a trademark application was filed for VARANA with the United States Patent and Trademark Office. The USPTO has given the VARANA trademark a serial number of 76294802. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, May 12, 2003. This trademark is owned by Pfizer Inc.. The VARANA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations and preparations for the treatment of gynecological disorders; pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of anxiety, depression, pain, gastrointestinal disorders, neuropsychiatric disorders including both psychotic and non-psychotic conditions, neurodegenerative disorders; and substance abuse disorders, including both abuse and dependence
varana

General Information

Serial Number76294802
Word MarkVARANA
Filing DateThursday, August 2, 2001
Status601 - ABANDONED - EXPRESS
Status DateMonday, May 12, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 13, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations and preparations for the treatment of gynecological disorders; pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of anxiety, depression, pain, gastrointestinal disorders, neuropsychiatric disorders including both psychotic and non-psychotic conditions, neurodegenerative disorders; and substance abuse disorders, including both abuse and dependence

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 17, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, May 12, 2003ABANDONMENT - EXPRESS MAILED
Monday, May 12, 2003PAPER RECEIVED
Tuesday, November 5, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 13, 2002PUBLISHED FOR OPPOSITION
Tuesday, August 13, 2002PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2002NOTICE OF PUBLICATION
Wednesday, May 22, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 11, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 2, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 14, 2001NON-FINAL ACTION MAILED
Wednesday, September 12, 2001ASSIGNED TO EXAMINER

Related Keywords

varana disorders preparations pharmaceutical diseases treatment both including dysfunction pain gastrointestinal